Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 188

1.

Association between the c.*229C>T polymorphism of the topoisomerase IIβ binding protein 1 (TopBP1) gene and breast cancer.

Forma E, Brzeziańska E, Krześlak A, Chwatko G, Jóźwiak P, Szymczyk A, Smolarz B, Romanowicz-Makowska H, Różański W, Bryś M.

Mol Biol Rep. 2013 May;40(5):3493-502. doi: 10.1007/s11033-012-2424-z. Epub 2013 Jan 1.

2.

Topoisomerase IIβ binding protein 1 c.*229C>T (rs115160714) gene polymorphism and endometrial cancer risk.

Forma E, Wójcik-Krowiranda K, Jóźwiak P, Szymczyk A, Bieńkiewicz A, Bryś M, Krześlak A.

Pathol Oncol Res. 2014 Jul;20(3):597-602. doi: 10.1007/s12253-013-9737-7. Epub 2013 Dec 18.

3.

The c.*229C > T gene polymorphism in 3'UTR region of the topoisomerase IIβ binding protein 1 gene and LOH in BRCA1/2 regions and their effect on the risk and progression of human laryngeal carcinoma.

Starska K, Forma E, Nowacka-Zawisza M, Lewy-Trenda I, Ciesielski P, Pietruszewska W, Skóra M, Bryś M.

Tumour Biol. 2016 Apr;37(4):4541-57. doi: 10.1007/s13277-015-4276-3. Epub 2015 Oct 27.

PMID:
26503213
4.

Identification of a common polymorphism in the TopBP1 gene associated with hereditary susceptibility to breast and ovarian cancer.

Karppinen SM, Erkko H, Reini K, Pospiech H, Heikkinen K, Rapakko K, Syväoja JE, Winqvist R.

Eur J Cancer. 2006 Oct;42(15):2647-52. Epub 2006 Aug 23.

PMID:
16930991
5.

Breast cancer risk and common single nucleotide polymorphisms in homologous recombination DNA repair pathway genes XRCC2, XRCC3, NBS1 and RAD51.

Silva SN, Tomar M, Paulo C, Gomes BC, Azevedo AP, Teixeira V, Pina JE, Rueff J, Gaspar JF.

Cancer Epidemiol. 2010 Feb;34(1):85-92. doi: 10.1016/j.canep.2009.11.002. Epub 2009 Dec 9.

PMID:
20004634
6.

FASL-844 T/C polymorphism: a biomarker of good prognosis of breast cancer in the Tunisian population.

Mahfoudh W, Bouaouina N, Gabbouj S, Chouchane L.

Hum Immunol. 2012 Sep;73(9):932-8. doi: 10.1016/j.humimm.2012.06.001. Epub 2012 Jun 22.

PMID:
22732091
7.

A genetic variant in p63 (rs17506395) is associated with breast cancer susceptibility and prognosis.

Zhang N, Huo Q, Wang X, Chen X, Long L, Guan X, Jiang L, Ma T, Hu W, Yang Q.

Gene. 2014 Feb 10;535(2):170-6. doi: 10.1016/j.gene.2013.11.038. Epub 2013 Dec 4.

PMID:
24316488
8.

A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers.

Wang WW, Spurdle AB, Kolachana P, Bove B, Modan B, Ebbers SM, Suthers G, Tucker MA, Kaufman DJ, Doody MM, Tarone RE, Daly M, Levavi H, Pierce H, Chetrit A, Yechezkel GH, Chenevix-Trench G, Offit K, Godwin AK, Struewing JP.

Cancer Epidemiol Biomarkers Prev. 2001 Sep;10(9):955-60.

9.

A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.

Singh V, Rastogi N, Sinha A, Kumar A, Mathur N, Singh MP.

Breast Cancer Res Treat. 2007 Jan;101(1):73-81. Epub 2006 Jun 29. Erratum in: Breast Cancer Res Treat. 2007 Apr;102(2):249.

PMID:
16807674
10.

Genetic variants at the miR-124 binding site on the cytoskeleton-organizing IQGAP1 gene confer differential predisposition to breast cancer.

Zheng H, Song F, Zhang L, Yang D, Ji P, Wang Y, Almeida M, Calin GA, Hao X, Wei Q, Zhang W, Chen K.

Int J Oncol. 2011 Apr;38(4):1153-61. doi: 10.3892/ijo.2011.940. Epub 2011 Feb 11.

PMID:
21318219
11.

TOPBP1 missense variant Arg309Cys and breast cancer in a German hospital-based case-control study.

Blaut MA, Bogdanova NV, Bremer M, Karstens JH, Hillemanns P, Dörk T.

J Negat Results Biomed. 2010 Nov 25;9:9. doi: 10.1186/1477-5751-9-9.

12.

Expression of TopBP1 in hereditary breast cancer.

Forma E, Krzeslak A, Bernaciak M, Romanowicz-Makowska H, Brys M.

Mol Biol Rep. 2012 Jul;39(7):7795-804. doi: 10.1007/s11033-012-1622-z. Epub 2012 Apr 28.

13.

Genetic variation in genes encoding for polymerase ζ subunits associates with breast cancer risk, tumour characteristics and survival.

Varadi V, Bevier M, Grzybowska E, Johansson R, Enquist K, Henriksson R, Butkiewicz D, Pamula-Pilat J, Tecza K, Hemminki K, Lenner P, Försti A.

Breast Cancer Res Treat. 2011 Aug;129(1):235-45. doi: 10.1007/s10549-011-1460-z. Epub 2011 Apr 1.

PMID:
21455670
14.

Genetic contribution of GADD45A to susceptibility to sporadic and non-BRCA1/2 familial breast cancers: a systematic evaluation in Chinese populations.

Yu KD, Di GH, Li WF, Rao NY, Fan L, Yuan WT, Hu Z, Wu J, Shen ZZ, Huang W, Shao ZM.

Breast Cancer Res Treat. 2010 May;121(1):157-67. doi: 10.1007/s10549-009-0516-9. Epub 2009 Sep 2.

PMID:
19728081
15.

Two-stage case-control study of common ATM gene variants in relation to breast cancer risk.

Ye C, Dai Q, Lu W, Cai Q, Zheng Y, Shu XO, Gu K, Gao YT, Zheng W.

Breast Cancer Res Treat. 2007 Nov;106(1):121-6. Epub 2007 Mar 13.

PMID:
17431766
16.

CD44 rs13347 C>T polymorphism predicts breast cancer risk and prognosis in Chinese populations.

Jiang L, Deng J, Zhu X, Zheng J, You Y, Li N, Wu H, Lu J, Zhou Y.

Breast Cancer Res. 2012 Jul 12;14(4):R105. doi: 10.1186/bcr3225.

17.

Combined effect of polymorphisms in Rad51 and Xrcc3 on breast cancer risk and chromosomal radiosensitivity.

Vral A, Willems P, Claes K, Poppe B, Perletti G, Thierens H.

Mol Med Rep. 2011 Sep-Oct;4(5):901-12. doi: 10.3892/mmr.2011.523. Epub 2011 Jul 1.

PMID:
21725594
18.

A population-based case-control study of the Arg399Gln polymorphism in DNA repair gene XRCC1 and risk of breast cancer.

Shu XO, Cai Q, Gao YT, Wen W, Jin F, Zheng W.

Cancer Epidemiol Biomarkers Prev. 2003 Dec;12(12):1462-7.

19.

A single-nucleotide polymorphism in the RAD51 gene modifies breast cancer risk in BRCA2 carriers, but not in BRCA1 carriers or noncarriers.

Kadouri L, Kote-Jarai Z, Hubert A, Durocher F, Abeliovich D, Glaser B, Hamburger T, Eeles RA, Peretz T.

Br J Cancer. 2004 May 17;90(10):2002-5.

20.

MDR1 C3435T polymorphism in patients with breast cancer.

Turgut S, Yaren A, Kursunluoglu R, Turgut G.

Arch Med Res. 2007 Jul;38(5):539-44. Epub 2007 Apr 26.

PMID:
17560460

Supplemental Content

Support Center